Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGS-200 in Osteoarthritic Knee Pain
NCT03528369Phase 2Completed
- Sponsor
- Propella Therapeutics
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin in osteoarthritis (OA), sponsored by Propella Therapeutics. Started May 2018; status: completed.
02
Drugs
capsaicin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03528369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03528369.